Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
L01XC31
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
||
|
NCI_THESAURUS |
C128057
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
||
|
FDA ORPHAN DRUG |
491815
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
||
|
NDF-RT |
N0000193338
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
||
|
FDA ORPHAN DRUG |
604117
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/15/1590
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
KXG2PJ551I
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
5221
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
100000166075
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
SUB180078
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
DE-160
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
1875534
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
1537032-82-8
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
DB11945
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
C116870
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
KXG2PJ551I
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
Avelumab
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
m11986
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
10062
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY | |||
|
Avelumab
Created by
admin on Wed Apr 02 09:50:45 GMT 2025 , Edited by admin on Wed Apr 02 09:50:45 GMT 2025
|
PRIMARY |
ACTIVE MOIETY